Sorted By:

Relevance


Week in review: The latest from PhRMA

PhRMA  |  Blog Post

IP projections critical to medical innovation – A new report from the Information Technology and Innovation Foundation (ITIF) highlights the importance of intellectual property protections in advancing innovation.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-april-8-2016

Strength in Numbers to Strengthen the System

PhRMA  |  Blog Post

Watching the Senate floor debate on Senator Patrick Leahy's patent reform bill, we were quite pleased to see the vast, vast majority of senators - 87 of them, in fact - vote to maintain the America Invents Act's first-to-file provision.
http://catalyst.phrma.org/strength-in-numbers-to-strengthen-the-system

PhRMA Encouraged by Decline in Cancer Death Rate

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-encouraged-by-decline-in-cancer-death-rate

4 recommendations for ICER

PhRMA  |  Blog Post

Read more about PhRMA’s policy solutions to promote value-driven health care here.
http://catalyst.phrma.org/4-recommendations-for-icer

Medicare Monday: What they are saying about MedPAC’s recommendations

PhRMA  |  Blog Post

” Morning Consult reported in April that more than 250 groups asked MedPAC not to move forward with the proposals.
http://catalyst.phrma.org/medicare-monday-what-they-are-saying-about-medpacs-recommendations

Australia is making it harder to protect inventions. That’s bad for American businesses and jobs.

PhRMA  |  Blog Post

Unfortunately, Australia is discouraging inventors from seeking injunctions to stop products that may violate a patent from entering the market.
http://catalyst.phrma.org/australia-is-making-it-harder-to-protect-inventions.-thats-bad-for-american-businesses-and-jobs

New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need

PhRMA  |  Blog Post

The PTC convened stakeholders from the patient, academic, medical, government and biopharmaceutical communities to produce its 2016 Advisory Report, which ultimately led to the formation of the I-ACT for Children.
http://catalyst.phrma.org/new-nonprofit-i-act-for-children-launched-to-promote-innovative-medicines-development-for-young-patients-in-need

Medicare Part D Continues to Hold Down Costs, Maintain High Level of Patient Satisfaction

PhRMA  |  Blog Post

A separate report by CBO in late-July found that net federal spending in 2013 came in at $50 billion as compared to the $99 billion initially projected when the program was enacted by Congress.
http://catalyst.phrma.org/medicare-part-d-continues-to-hold-down-costs-maintain-high-level-of-patient-satisfaction

PhRMA Statement on Expanding Healthcare Coverage

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-expanding-healthcare-coverage

PhRMA Statement Regarding Benefits of New Medicines

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-regarding-benefits-of-new-medicines

Which 340B Entities Are Getting Most of the Savings?

PhRMA  |  Blog Post

View all 340B Spotlight Posts [1] Alliance for Integrity and Reform of 340B, "Unfulfilled Expectations: An analysis of charity care provided by 340B hospitals," Spring 2014 (Available at: http://340breform.org/userfiles/Final%20AIR%20340B%20Charity%20Care%20Paper.pdf) [2] Department of Health and Human Services Office of Inspector General, "Memorandum Report: Contract Pharmacy Arrangements in the 340B Program," February 2014 (Available at: https://oig.hhs.gov/oei/reports/oei-05-13-00431.pdf)
http://catalyst.phrma.org/which-340b-entities-are-getting-most-of-the-savings

America’s Pharmaceutical Companies Stand Ready to Assist Kentucky Residents Affected by Floodsq

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/america-s-pharmaceutical-companies-stand-ready-to-assist-kentucky-residents-affected-by-floodsq

America’s Pharmaceutical Companies Assist Tennessee Residents Affected by Floods

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/america-s-pharmaceutical-companies-assist-tennessee-residents-affected-by-floods

New surveys find payers and providers want more data from biopharmaceutical companies

PhRMA  |  Blog Post

View the survey findings here.
http://catalyst.phrma.org/new-surveys-find-payers-and-providers-want-more-data-from-biopharmaceutical-companies

Insurance Coverage

PhRMA  |  From PhRMA

For more on insurance coverage basics visit Access Better Coverage and for comprehensive reports on coverage and access explore 123s: By the Numbers.
https://www.phrma.org/advocacy/access/insurance-coverage

PhRMA Response to Senate Finance Committee Draft Summary

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-response-to-senate-finance-committee-draft-summary

How much are hospitals marking up the price of medicines? The answer may surprise you.

PhRMA  |  Blog Post

View the full analysis here.
http://catalyst.phrma.org/how-much-are-hospitals-marking-up-the-price-of-medicines-the-answer-may-surprise-you

Medicare Monday: Negotiation in Medicare Part D works

PhRMA  |  Blog Post

Across the 12 therapeutic classes of widely used medicines in Part D the report analyzed, net costs to plans for prescription drugs ranged from 31 to 54 percent of list price.
http://catalyst.phrma.org/medicare-monday-negotiation-in-medicare-part-d-works

Canada’s innovation opportunity

PhRMA  |  Blog Post

Recommended read: Canada's chance to reform its approach to innovation
http://catalyst.phrma.org/canadas-innovation-opportunity

New Video: Clinical trials serve as engine for local economic growth

PhRMA  |  Blog Post

It also highlights a 2013 review of biopharmaceutical industry sponsored site-based clinical trials, revealing that the industry: Sponsored nearly 6,200 site-based clinical trials with 1.1 million participations; Invested close to $10 billion to conduct clinical trials at sites in 50 states;  and Generated $25 billion in economic impact from conducting clinical trials across the U.S.
http://catalyst.phrma.org/new-video-clinical-trials-serve-as-engine-for-local-economic-growth

PhRMA Principles for Payment and Delivery System Reforms

PhRMA  |  Codes & Guidelines

Payment Reform: Analysis of Models and Performance Measurement Implications.
https://www.phrma.org/codes-and-guidelines/phrma-principles-for-payment-and-delivery-system-reforms

Critics Say High Deductibles Make Insurance ‘Unaffordable’

Access Better Coverage  |  From Our Network

In fact, the growing use and size of deductibles as a way to lower premiums “threatens to undermine the gains Americans have made in coverage since 2014,” according to a September report by The Commonwealth Fund on the affordability of marketplace plans.
http://www.accessbettercoverage.org/social-news/critics-say-high-deductibles-make-insurance-unaffordable

New video: Patient and researcher fight JRA together

PhRMA  |  Blog Post

Thanks to researchers like Dawn, there are more than 70 medicines in development to help treat autoimmune arthritis like JRA.
http://catalyst.phrma.org/new-video-patient-and-researcher-fight-jra-together

In the OECD other health care services will be ten times prescription medicine spending growth over next decade

PhRMA  |  Blog Post

To learn more check out our International Cost in Context information.
http://catalyst.phrma.org/in-the-oecd-other-health-care-services-will-be-ten-times-prescription-medicine-spending-growth-over-next-decade

Medicare Monday: Did You Know Four out of Five Part D Prescriptions Are Generic?

PhRMA  |  Blog Post

Since Part D’s implementation and the creation of a marketplace for older Americans to access needed medicines, generic utilization has increased steadily to 84 percent in 2013 and 85 percent in 2014 (as recently reported by the Medicare Trustees).
http://catalyst.phrma.org/medicaremonday-did-you-know-four-out-of-five-part-d-prescriptions-are-generic

You have reviewed the first 450 results out of 1029. Each page contains 25 results. You're on page 18.

prev 13 14 15 16 17 18 next